Submit Your Feeds

Business News • PR NewsWire • Positive Interactions With EMA Provide Route to Conditional Marketing Authorization of Lead Candidate Nefecon

Positive Interactions With EMA Provide Route to Conditional Marketing Authorization of Lead Candidate Nefecon
Positive Interactions With EMA Provide Route to Conditional Marketing Authorization of Lead Candidate Nefecon

STOCKHOLM, Oct. 1, 2019 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the European Medicines Agency (EMA) has provided positive guidance related to a conditional marketing authorization (CMA) of the company's lead compound Nefecon, currently in...

View More : https://www.prnewswire.com:443/news-releases/positive-interactions-with-ema-provide-route-to-conditional-marketing-autho...
Releted News by prnewswire
Nordic Nanovector Appoints Dr Gabriele Elbl as Vice President Global Regulatory Affairs
Hall & Partners cierra dos nuevas contrataciones importantes en Salud
Vieworks to expand 25MP CMOS area scan camera lineup
Positive Interactions With EMA Provide Route to Conditional Marketing Authorization of Lead Candidate Nefecon
Change of the Election Committee of Castellum AB Before the AGM 2020
Nanofibers Market to Witness Steady Growth Based on Enhanced Scope of Application in Air & Liquid Filters and High Demand From Electronics Segment Till 2024 | Million Insights
Pacific Northwest healthcare insurance innovator, HMA, is first-to-market with new doctor quality comparison technology
Home Sitemap Contact Us
© businessNewsNewsNews.com